• Skip to content
  • Skip to primary sidebar

PEDro

Physiotherapy Evidence Database

Quality of trials in musculoskeletal physiotherapy is suboptimal

15/11/2017 by PEDro Leave a Comment

An exploration of the methodological quality and completeness of statistical reporting of trials evaluating physiotherapy intervention for musculskeletal conditions has recently been published. A random sample of ~20% of musculoskeletal trials indexed on PEDro were evaluated (n=1,404). We downloaded PEDro scale data, therapy codes plus year and language of publication from PEDro; evaluated each article using 9 items from the CONSORT checklist; and ascertained whether the journal publishing each trial endorsed the CONSORT statement. The mean total PEDro score was 5.3/10 (standard deviation 1.6). There was a slight improvement in the quality of trial reports over time. The characteristics that were associated with a higher total PEDro score were: journal endorsement of the CONSORT statement, reporting the sample size calculation, a lower number of primary outcomes, evaluation of electrotherapy as intervention, if the trial reported the research design in the title, inclusion of a participant flow diagram, trials published more recently, and trials published in English. The quality of the trials in musculoskeletal physiotherapy is suboptimal. Researchers are encouraged to use the CONSORT statement when designing and reporting their trials. Use of the CONSORT statement by journal reviewers and journal editors’ would also improve the quality of trial reports in musculoskeletal physiotherapy.

Zoldan Gonzalez G et al. Quality of musculoskeletal trials: methodological quality and statistical reporting of physical therapy randomized controlled trials relevant to musculoskeletal conditions. Arch Phys Med Rehabil 2017 Sep 26: Epub ahead of print

#PhysicalTherapy #physio

Filed Under: English blog

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Simple search
  • Advanced search
  • English
    • Frequently asked questions
    • Search help
    • Downloads
      • EndNote filter
      • RefWorks filter
      • PEDro information leaflet
      • PEDro statistics
      • PEDro scale
      • Criteria
      • Codes
      • Confidence interval calculator
    • Tutorials
      • How to ask a clinical question
      • Is the trial valid?
      • Is the therapy clinically useful?
      • PEDro scale training program
    • Links
    • PEDro publications
    • British Journal of Sports Medicine
    • Supporters
    • Evidence in your inbox
    • About us
      • CEBP
      • Structure
      • Roles
      • Contact details
    • Archive
      • Top 15 trials
        • Efficacy of traction for non-specific low back pain
        • Stratified primary care management for low back pain
        • McKenzie method for acute low back pain
        • Diclofenac and manipulation for acute low back pain
        • Fitness training for chronic low back pain
        • Mobilisation and exercise for tennis elbow
        • Extracorporeal shock wave therapy for plantar fasciitis
        • Exercises to prevent lower limb injuries
        • Circuit class training in stroke rehabilitation
        • Constraint-induced movement therapy after stroke
        • Physiotherapy for Bell’s palsy
        • Early therapy in critically ill patients
        • Pelvic floor exercises for genuine stress incontinence
        • Exercise for older persons
      • Press releases
        • 5 myths busted
        • 5 exercise tips
      • Newsletters
    • Blog
  • 简体中文
  • 繁体中文
  • Português
  • Deutsch
  • Français
  • Español
  • Italiano
  • 日本語
  • 한국어
  • Türkçe
  • தமிழ்

Footer

Neuroscience Research Australia
The University of Sydney

The database was last updated on 9 April 2018 (this includes records added or amended since 5 March 2018).
The next update is planned for Monday 7 May 2018. The total number of records on the database is 39,633.

  • Contact us
  • Sitemap
  • Accessibility statement
  • Fair use statement
  • Twitter
  • Facebook
  • Google+
  • YouTube